These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38491354)

  • 1. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
    Wang X; Liu X; Dai H; Jia J
    BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.
    Li P; Qin P; Fu X; Zhang G; Yan X; Zhang M; Zhang X; Yang J; Wang H; Ma Z
    Ann Palliat Med; 2021 Mar; 10(3):3039-3049. PubMed ID: 33849094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive response and outcome of peripheral CD4
    Gao D; Liu L; Liu J; Liu J
    Int Immunopharmacol; 2024 Mar; 129():111663. PubMed ID: 38364744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating memory PD-1
    Liu J; Liu D; Hu G; Wang J; Chen D; Song C; Cai Y; Zhai C; Xu W
    Cancer Cell Int; 2023 Nov; 23(1):274. PubMed ID: 37974194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
    Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the CD4
    Xu S; Zhu Q; Wu L; Wang Y; Wang J; Zhu L; Zheng S; Hang J
    Int Immunopharmacol; 2023 Oct; 123():110642. PubMed ID: 37499395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients.
    Liu A; Xia Y; Li W; Zhang G; Liu Y; Ye S; Zhao ZR; Yang Y; Jia Y; Guo Y; Liu X; Chen H; Yu J
    Contrast Media Mol Imaging; 2022; 2022():3444360. PubMed ID: 36051923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.
    Liu A; Zhang G; Yang Y; Xia Y; Li W; Liu Y; Cui Q; Wang D; Yu J
    Cancer Immunol Immunother; 2024 Jun; 73(8):152. PubMed ID: 38833153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of peripheral CD3
    Zhang S; Li L; Liu C; Pu M; Ma Y; Zhang T; Chai J; Li H; Yang J; Chen M; Kong L; Xia T
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):365. PubMed ID: 39052085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced 
Non-small Cell Lung Cancer and Its Therapeutic Effect].
    Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic analysis of related factors of adverse reactions to immunotherapy in advanced gastric cancer and establishment of a nomogram model.
    He XX; Du B; Wu T; Shen H
    World J Gastrointest Oncol; 2024 Apr; 16(4):1268-1280. PubMed ID: 38660670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pembrolizumab on T lymphocyte subsets in patients with advanced oral cancer and its therapeutic effect.
    Feng L; Li TK; Yin K; Zhang SX; Chen Z; Bao Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30534. PubMed ID: 36086675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study.
    Wang Y; Zhu J; Zhou N; Wang Y; Zhang X
    J Thorac Dis; 2023 Oct; 15(10):5669-5679. PubMed ID: 37969284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma.
    Xie Q; Hu C; Luo C
    J Cancer; 2023; 14(15):2946-2955. PubMed ID: 37781071
    [No Abstract]   [Full Text] [Related]  

  • 16. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
    Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral blood lymphocyte subsets predict the efficacy of TACE with or without PD-1 inhibitors in patients with hepatocellular carcinoma: a prospective clinical study.
    Wang H; Huang H; Liu T; Chen Y; Li J; He M; Peng J; Liang E; Li J; Liu W
    Front Immunol; 2024; 15():1325330. PubMed ID: 38404585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Xu X; Wang D; Chen W; Li N; Suwinski R; Rossi A; Rosell R; Zhong J; Fan Y
    Transl Lung Cancer Res; 2021 Dec; 10(12):4511-4525. PubMed ID: 35070757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.
    Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY
    Front Immunol; 2018; 9():727. PubMed ID: 29910795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.